Status:
UNKNOWN
Narrow Band Imaging for Gastric Neoplasia
Lead Sponsor:
University of Southern California
Collaborating Sponsors:
Universidade do Porto
Conditions:
Gastric Cancer
Gastric Metaplasia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
It is thought that the development of cancer of the stomach follows a series of stages in which the lining becomes increasingly abnormal. Early detection of precursors of gastric cancer likely enable ...
Detailed Description
1 BACKGROUND Precursor Lesions Gastric cancer is the fourth most common cancer and second leading cause of malignant death in the world. It often presents only with vague symptoms of dyspepsia and c...
Eligibility Criteria
Inclusion
- presenting for upper endoscopy for gastric indications
- gastric indications include upper abdominal pain dyspepsia abnormal gastric imaging iron deficiency anemia gastric ulcer management of GI blood loss without active bleeding reflux weight loss.
Exclusion
- Subjects who are incarcerated, younger than 18, or unable to give informed consent will be excluded.
- Patients who have evidence of active gastrointestinal bleeding will be excluded
- Patients taking anti-thrombotic agents including clopidogrel, ticlopidine, coumadin, heparin, enoxaparin, and direct II or Xa inhibitors
- Patients with INR \>1.5, platelet count \<75,000
Key Trial Info
Start Date :
July 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT02197351
Start Date
July 1 2014
End Date
December 1 2023
Last Update
March 6 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Los Angeles County Hospital
Los Angeles, California, United States, 90033
2
Department of Gastroenterology Portuguese Oncology Institute of Porto
Porto, Portugal